APA (7th ed.) Citation

SL, Y., YQ, H., CT, L., DQ, X., & X, Z. (2026). [Research progress on the role of the microbiota-gut-liver axis immune pathway in metabolic dysfunction-associated steatotic liver disease]. Sheng li xue bao : [Acta physiologica Sinica], 78(3), 579. https://doi.org/10.13294/j.aps.2025.0075

Chicago Style (17th ed.) Citation

SL, Yuan, Huang YQ, Li CT, Xu DQ, and Zheng X. "[Research Progress on the Role of the Microbiota-gut-liver Axis Immune Pathway in Metabolic Dysfunction-associated Steatotic Liver Disease]." Sheng Li Xue Bao : [Acta Physiologica Sinica] 78, no. 3 (2026): 579. https://doi.org/10.13294/j.aps.2025.0075.

MLA (9th ed.) Citation

SL, Yuan, et al. "[Research Progress on the Role of the Microbiota-gut-liver Axis Immune Pathway in Metabolic Dysfunction-associated Steatotic Liver Disease]." Sheng Li Xue Bao : [Acta Physiologica Sinica], vol. 78, no. 3, 2026, p. 579, https://doi.org/10.13294/j.aps.2025.0075.